132 reports of this reaction
3.5% of all VECURONIUM BROMIDE reports
#1 most reported adverse reaction
RENAL FAILURE is the #1 most commonly reported adverse reaction for VECURONIUM BROMIDE, manufactured by Eugia US LLC. There are 132 FDA adverse event reports linking VECURONIUM BROMIDE to RENAL FAILURE. This represents approximately 3.5% of all 3,750 adverse event reports for this drug.
Patients taking VECURONIUM BROMIDE who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL FAILURE is moderately reported among VECURONIUM BROMIDE users, representing a notable but not dominant share of adverse events.
In addition to renal failure, the following adverse reactions have been reported for VECURONIUM BROMIDE:
The following drugs have also been linked to renal failure in FDA adverse event reports:
RENAL FAILURE has been reported as an adverse event in 132 FDA reports for VECURONIUM BROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL FAILURE accounts for approximately 3.5% of all adverse event reports for VECURONIUM BROMIDE, making it one of the most commonly reported side effect.
If you experience renal failure while taking VECURONIUM BROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.